SCHF - ETF AI Analysis
Top Page
Schwab International Equity ETF (SCHF)
Rating:62Neutral
Price Target:―
Positive Factors
Very Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries such as Japan, the UK, Europe, Canada, and Australia help reduce the impact of problems in any single market.
Strong Contribution from Key Holdings
Several top positions, including ASML, HSBC, Shell, and Commonwealth Bank of Australia, have shown strong or steady performance, supporting the ETF’s recent gains.
Negative Factors
Limited U.S. Focus
Because this is an international fund with only modest U.S. exposure, it may lag when U.S. stocks are leading global markets.
Exposure to Lagging Blue-Chip Stocks
Some major holdings like Nestlé, Roche, and Toyota have shown weaker recent performance, which can drag on overall returns.
Heavy Weight in Financials
A sizable allocation to financial companies means the fund can be more sensitive to changes in interest rates and banking sector stress.
SCHF vs. SPDR S&P 500 ETF (SPY)
AUM62.13B
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.77
IssuerSchwab
Inception DateNov 03, 2009
Dividend Yield3.17%
Asset ClassEquity
Index TrackedFTSE All-World Developed x US
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,094,463
30 Day Avg. Volume12,968,810
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.47Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1309
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SCHF Summary
SCHF is the Schwab International Equity ETF, which follows the FTSE Developed ex US Index. That means it invests in many companies from developed countries outside the United States, such as Japan, the UK, and Europe. It holds well-known names like Nestlé, Toyota, and HSBC, and spreads money across many sectors, including financials, industrials, and health care. Someone might invest in SCHF to diversify beyond U.S. stocks and tap into long-term growth in global markets at a low cost. A key risk is that international stocks can be volatile and can go up or down with global market and currency swings.
How much will it cost me?The Schwab International Equity ETF (SCHF) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because SCHF is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?The Schwab International Equity ETF (SCHF) could benefit from global economic growth, particularly in developed markets outside the U.S., as well as advancements in sectors like technology and healthcare, which are among its top holdings. However, it may face challenges from rising interest rates, currency fluctuations, or geopolitical tensions that could negatively impact international markets and sectors like financials and energy. Regulatory changes in key regions or slower growth in developed economies could also affect its performance.
SCHF Top 10 Holdings
SCHF leans heavily on a global mix of financials, health care, and a touch of tech, with all of its firepower outside the U.S. ASML is one of the main engines, rising on strong chip-equipment demand, while HSBC and Royal Bank of Canada add steady lift from the banking side. Big pharma names AstraZeneca and Novartis are also quietly pulling their weight. On the flip side, Roche has been lagging and Toyota has lost some traction, with Nestlé looking more sluggish than defensive, slightly dampening the fund’s otherwise solid tone.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.02% | $1.25B | €477.33B | 106.32% | 76 Outperform | |
| HSBC Holdings | 1.09% | $673.13M | £226.99B | 58.35% | 80 Outperform | |
| Roche Holding AG | 1.03% | $633.86M | $327.04B | 22.13% | 73 Outperform | |
| AstraZeneca | 1.01% | $620.99M | $292.69B | 32.74% | 80 Outperform | |
| Novartis AG | 0.99% | $610.29M | CHF207.57B | 22.14% | 80 Outperform | |
| Nestlé SA | 0.95% | $584.67M | CHF205.30B | -1.29% | 71 Outperform | |
| Shell (UK) | 0.90% | $558.75M | £184.86B | 32.32% | 73 Outperform | |
| Royal Bank Of Canada | 0.87% | $540.18M | $245.63B | 48.99% | 75 Outperform | |
| Siemens | 0.74% | $459.95M | €185.31B | 21.53% | 74 Outperform | |
| Commonwealth Bank of Australia | 0.74% | $458.60M | AU$291.71B | 6.28% | 64 Neutral |
SCHF Technical Analysis
Neutral
―
Price Trends
25.70
Positive
25.26
Positive
23.87
Positive
Market Momentum
0.23
Positive
49.87
Neutral
22.52
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHF, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 26.09, equal to the 50-day MA of 25.70, and equal to the 200-day MA of 23.87, indicating a neutral trend. The MACD of 0.23 indicates Positive momentum. The RSI at 49.87 is Neutral, neither overbought nor oversold. The STOCH value of 22.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SCHF.
SCHF Peer Comparison
Comparison Results
Performance Comparison
SCHF
Schwab International Equity ETF
25.91
6.13
30.99%
VEA
Vanguard FTSE Developed Markets ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents